|
Trial no.:
|
PACTR201310000604277 |
Date of Registration:
|
29/07/2013 |
|
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
| TRIAL DESCRIPTION |
|
Public title
|
Acetylation phenotype and clinical implications in tuberculosis patients |
| Official scientific title |
- Profile of Isoniazid Acetylation Phenotype and Clinical Implications in Rwandan Healthy Subjects and Tuberculosis Patients |
|
Brief summary describing the background
and objectives of the trial
|
Numerous studies have been reported in literature demonstrating how an individual's genetic profile may be used for adjusting drug dosage. We designed this study to have indicative pictures on the normal profile of isoniazid acetylator phenotype, the effect of Tuberculosis (TB) on the profile, and the impact clinical responses. |
| Type of trial |
CCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Infections and Infestations |
| Sub-Disease(s) or condition(s) being studied |
Tuberculosis |
| Purpose of the trial |
Treatment: Drugs |
| Anticipated trial start date |
01/01/2011 |
| Actual trial start date |
02/04/2011 |
| Anticipated date of last follow up |
03/04/2012 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
50 |
| Actual target sample size (number of participants) |
42 |
| Recruitment status |
Completed |
| Publication URL |
|
|